Detalhe da pesquisa
1.
Impact of academic medical center access on outcomes in multiple myeloma.
Am J Hematol
; 98(1): 41-48, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266759
2.
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(11): 1277-1303, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781268
3.
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.
J Oncol Pharm Pract
; 24(3): 190-197, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436250
4.
Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
Br J Haematol
; 198(6): e78-e81, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876645
5.
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.
Blood
; 125(11): 1772-81, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573989
6.
An inherited disorder with splenomegaly, cytopenias, and vision loss.
Am J Med Genet A
; 158A(3): 475-81, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22307799
7.
Locally recurrent endometrial cancer: a case report.
J Natl Compr Canc Netw
; 10(4): 442-5, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491044
8.
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study.
Lancet Haematol
; 9(6): e434-e444, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576960
9.
A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.
Blood Adv
; 6(2): 405-409, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649277
10.
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy.
J Clin Oncol
; 40(15): 1671-1680, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180010
11.
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.
Leukemia
; 34(11): 2981-2991, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409689
12.
Systemic mastocytosis in a patient with Cowden syndrome.
Am J Hematol
; 89(12): 1154, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25059215
13.
The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.
Blood Adv
; 3(20): 2949-2961, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648319
14.
Minimal Residual Disease Eradication in CML: Does It Really Matter?
Curr Hematol Malig Rep
; 12(5): 495-505, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28852963
15.
Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies.
Clin Genitourin Cancer
; 14(2): 153-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26781820
16.
Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis.
Am J Clin Oncol
; 39(5): 497-506, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24824144
17.
In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab.
Leukemia
; 34(1): 317-321, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409922
18.
Correlation of degree of hypothyroidism with survival outcomes in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Clin Genitourin Cancer
; 13(3): e131-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25497584
19.
Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.
J Oncol
; 2015: 181926, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25688268
20.
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
Leukemia
; 29(3): 586-597, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25134459